Dr Reddy's Laboratories enters into supply & licensing agreement with PanTheryx Inc.
To market & distribute breakthrough nutritional intervention, DiaResQ
Dr Reddy's Laboratories and PanTheryx Inc. announced a multi-country supply and licensing agreement. The agreement grants Dr Reddy's the exclusive right to market and distribute PanTheryxs' breakthrough nutritional intervention, DiaResQ, for infectious diarrhea in India and Nepal and in process for Russia, Myanmar, Vietnam, Sri Lanka, Kazakhstan, Belarus, Jamaica and select LATAM markets. Dr Reddy's will market the product in India and Nepal under the 'Reliqua' brand.Powered by Capital Market - Live News